Elscint has reinforced its reputation for ongoing structural change by again reorganizingits nuclear medicine and CT/MRI sales and marketing groups. Changes announced March 1 are intended to give the units clearlydefined lines of responsibility,
Elscint has reinforced its reputation for ongoing structural change by again reorganizingits nuclear medicine and CT/MRI sales and marketing groups.
Changes announced March 1 are intended to give the units clearlydefined lines of responsibility, according to Donald J. Southard,vice president of sales and marketing. The key appointment isthe selection of John Ariatti as business unit director and actingwestern regional manager for CT/MRI.
Ariatti was formerly director of sales, marketing and customersupport for Otsuka Electronics in Fort Collins, CO. Prior to that,he was MRI marketing director and CT business unit manager forToshiba America Medical Systems.
Elscint Ltd., the parent company of Elscint, Inc., purchasedOtsuka's MRI business. Those assets have been renamed ElscintMR, Inc.
Israel Ohana has departed as nuclear medicine product managerand Southard has temporarily assumed that role. Southard joinedElscint as part of a 1994 restructuring effort, after servingas president and CEO of Serviscope, an independent service organizationin Wallingford, CT.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.